Trial of New Oral Anticoagulants vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
Phase of Trial: Phase III
Latest Information Update: 31 May 2019
Price : $35 *
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Stroke; Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms NEW-AF
- 25 May 2019 Status changed from not yet recruiting to recruiting.
- 27 Mar 2019 Planned number of patients changed from 200 to 300.
- 08 Mar 2019 Planned End Date changed from 1 Jan 2022 to 1 May 2022.